Use of alcohol, nicotine and other drugs in the Western Australian HIV Cohort study
Susan E. Herrmann A D , Elizabeth J. McKinnon A , Leah J. Williams B , Mina John A B , Simon Mallal A B , Michaela Lucas A C and David A. Nolan A B
+ Author Affiliations
- Author Affiliations
A Institute for Immunology & Infectious Diseases, Murdoch University, Building 390, Discovery Way, Murdoch, WA 6150, Australia.
B Department of Immunology, Royal Perth Hospital, Perth, WA 6000, Australia.
C Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia.
D Corresponding author. Email: s.herrmann@murdoch.edu.au
Sexual Health 9(2) 199-201 https://doi.org/10.1071/SH11085
Submitted: 9 June 2011 Accepted: 28 July 2011 Published: 30 March 2012
Abstract
Self-report questionnaires on alcohol, nicotine and other drugs were administered to assess the current prevalence of alcohol, drug and nicotine use in our tertiary HIV service and inform the establishment of effective interventions. Many respondents reported use of alcohol over the preceding month (111 out of 152, 73%), and recent drug use (48 out of 137, 35%) and frequently both. Sessional alcohol consumption was prevalent among drinkers (52 out of 111, 47%), and correlated with both early treatment phase (P = 0.009) and non-adherence (P = 0.03). Encouraged by a notable proportion of patients expressing interest in clinic-based smoking cessation counselling, we recommend a targeted education strategy to motivate patients in health-seeking behaviours.
Additional keywords: intervention, marijuana, non-adherence.
References
[1] Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005; 7 511–22.| Tobacco use and readiness to quit smoking in low-income HIV-infected persons.Crossref | GoogleScholarGoogle Scholar | 16085522PubMed |
[2] Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, et al The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study. J Stud Alcohol 2002; 63 179–86.
| 12033694PubMed |
[3] Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009; 4 314–8.
| HIV, alcohol, and noninjection drug use.Crossref | GoogleScholarGoogle Scholar | 19532070PubMed |
[4] Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20 731–9.
| Risk factors for HIV infection among men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 16514304PubMed |
[5] Woolf SE, Maisto SA. Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav 2009; 13 757–82.
| Alcohol use and risk of HIV infection among men who have sex with men.Crossref | GoogleScholarGoogle Scholar | 18236149PubMed |
[6] Azar M, Springer S, Meyer J, Altice F. A systematic review of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend 2010; 112 178–93.
| A systematic review of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.Crossref | GoogleScholarGoogle Scholar | 20705402PubMed |
[7] Braithwaite R, Bryant K. Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health 2010; 33 280–7.
[8] Mohapatra S, Patra J, Popova S, Duhig A, Rehm J. Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health 2010; 55 149–57.
| Social cost of heavy drinking and alcohol dependence in high-income countries.Crossref | GoogleScholarGoogle Scholar | 20024666PubMed |
[9] Meeting Report, Prevention and Treatment of HIV/AIDS amongst Drug Using Populations: A Global Perspective. Meeting supported by the National Institute on Drug Abuse and the International AIDS Society, 2010. Washington, DC: International AIDS Society; 2010.
[10] Sullivan LE, Saitz R, Cheng DM, Libman H, Nunes D, Samet JH. The impact of alcohol use on depressive symptoms in HIV-infected patients. Addiction 2008; 103 1461–7.
| The impact of alcohol use on depressive symptoms in HIV-infected patients.Crossref | GoogleScholarGoogle Scholar | 18637000PubMed |
[11] Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, et al Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS 2001; 15 615–24.
| Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD38%2Fmt1Clsg%3D%3D&md5=98db1d6c133b4ae19856d771c45e1e00CAS | 11788076PubMed |
[12] Clifford GM, Polesel J, Rickenbach M, Maso LD, Keiser O, Kofler A, et al Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97 425–32.
| Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.Crossref | GoogleScholarGoogle Scholar | 15770006PubMed |
[13] Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, et al Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23 41–50.
| Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.Crossref | GoogleScholarGoogle Scholar | 19050385PubMed |
[14] Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 2010; 26 511–8.
| Alcohol use accelerates HIV disease progression.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXmtFKruro%3D&md5=da140456ad0c0656cb25c240ad34ed0fCAS | 20455765PubMed |
[15] Ma Q, Fehintola F, Zingman B. Tobacco and marijuana uses significantly lower atazanavir (ATV) trough concentrations in HIV-infected individuals. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009); 2009, Sept 12–15; San Francisco, CA, USA. Abstract H-231.
[16] Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, et al Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee. AIDS Care 2000; 12 255–66.
| Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3cvhslKgsA%3D%3D&md5=df9d4ac42619e5498e2e4f6f08b8fa56CAS | 10928201PubMed |
[17] Herrmann S, McKinnon E, John M, Hyland N, Martinez OP, Cain A, et al Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care. Intern Med J 2008; 38 8–15.
| 1:STN:280:DC%2BD1c%2FisFCkuw%3D%3D&md5=8b1c9d60d34c97632a667c2c6bdb4261CAS | 17916167PubMed |
[18] Kalichman S, Amaral C, White D, Swetsze C, Pope H, Kalichman M, et al Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS 2009; 23 449–54.
| Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS.Crossref | GoogleScholarGoogle Scholar | 19413503PubMed |
[19] Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev 2009; 21 94–105.
| Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.Crossref | GoogleScholarGoogle Scholar | 19537957PubMed |
[20] Miller WR, Rollnick S. Motivational interviewing: preparing people for change. New York: The Guilford Press; 2002.
[21] Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction 2004; 99 361–8.
| Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.Crossref | GoogleScholarGoogle Scholar | 14982549PubMed |
[22] Sobell LC, Sobell MB. Using motivational interviewing techniques to talk with clients about their alcohol use. Cognit Behav Pract 2003; 10 214–21.
| Using motivational interviewing techniques to talk with clients about their alcohol use.Crossref | GoogleScholarGoogle Scholar |
[23] Hajek P, Taylor T, McRobbie H. The effect of stopping smoking on perceived stress levels. Addiction 2010; 105 1466–71.
| The effect of stopping smoking on perceived stress levels.Crossref | GoogleScholarGoogle Scholar | 20528815PubMed |
[24] Vidrine D, Arduino R, Gritz E. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS 2007; 21 659–66.
| The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS.Crossref | GoogleScholarGoogle Scholar | 17919093PubMed |
